Form 4: GlycoMimetics Director Acquires Stock Options
SEC Form 4 Filing
Patricia S. Andrews, a director of GlycoMimetics Inc., acquired stock options for 40,000 shares on May 1, 2024.
Summary
- On May 1, 2024, Patricia S. Andrews, a director of GlycoMimetics Inc. (GLYC), acquired stock options to purchase 40,000 shares of common stock at an exercise price of $1.62.
- The options vest on May 1, 2025, contingent upon the director's continued service.
- The options expire on April 30, 2034.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock option grants to a company director. It doesn't inherently indicate positive or negative sentiment, but rather provides information about insider transactions.
Industry Context
Form 4 filings are standard disclosures required by the SEC when insiders (directors, officers, or those holding 10% or more of a company's shares) transact in their company's stock. These filings provide transparency to the market regarding insider activity.
Stakeholder Impact
- The transaction could signal confidence in the company's future prospects from a director's perspective, potentially influencing investor sentiment.
Key Dates
| Date | Description |
|---|---|
| 05/01/2024 | Date of transaction: Director acquired stock options. |
| 05/01/2025 | Vesting date for the stock options, contingent upon continued service. |
| 04/30/2034 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.